ATTO (Attovia Therapeutics) FCF Margin %: 0.00% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ATTO Attovia Therapeutics Inc ATTO
8 GF Score
Price $21.07
View Full Analysis

What is Attovia Therapeutics FCF Margin %?

Attovia Therapeutics ATTO -3.79% 8 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates ATTO with a GF Score™ of 8/100.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Attovia Therapeutics's Free Cash Flow for the three months ended in Mar. 2026 was $-18.43 Mil. Attovia Therapeutics's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Attovia Therapeutics's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Attovia Therapeutics's current FCF Yield % is -166,700.00%.

The historical rank and industry rank for Attovia Therapeutics's FCF Margin % or its related term are showing as below:

ATTO' s FCF Margin % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0
Current: -1365.11

ATTO's FCF Margin % is not ranked
in the Biotechnology industry.
Industry Median: -78.04 vs ATTO: -1365.11

Attovia Therapeutics FCF Margin % Related Terms

Attovia Therapeutics FCF Margin % Historical Data

* Premium members only.

The historical data trend for Attovia Therapeutics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Attovia Therapeutics FCF Margin % Chart

Attovia Therapeutics Annual Data
Trend Dec24 Dec25
FCF Margin %
0.00 -4,556.44

Attovia Therapeutics Quarterly Data
Dec24 Mar25 Dec25 Mar26
FCF Margin % 0.00 0.00 0.00 0.00

ATTO vs : FCF Margin % Comparison

For the Biotechnology subindustry, Attovia Therapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Attovia Therapeutics FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Attovia Therapeutics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Attovia Therapeutics's FCF Margin % falls into.


ATTO
8GF Score
Attovia Therapeutics Inc ATTO
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Attovia Therapeutics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Attovia Therapeutics's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-61.512/1.35
=-4,556.44 %

Attovia Therapeutics's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-18.429/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Attovia Therapeutics (ATTO) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Attovia Therapeutics and its competitors.
Is Attovia Therapeutics' FCF Margin % too high?
Attovia Therapeutics' current FCF Margin % is 0.00%. Overall, Attovia Therapeutics has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Attovia Therapeutics' FCF Margin % compare to ?
Attovia Therapeutics' FCF Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Attovia Therapeutics and its competitors. Attovia Therapeutics's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Attovia Therapeutics stock overvalued right now?
Attovia Therapeutics (ATTO) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Attovia Therapeutics' overall GF Score™ is 8/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Attovia Therapeutics (ATTO), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Attovia Therapeutics Business Description

Comparable Companies
Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases. Its product pipeline includes ATTO-1310 and ATTO-2306 for immune-dermatology indications and ATTO-1091 for inflammatory diseases, including inflammatory bowel disease (IBD). The company's product candidates are developed using its ATTOBODY biologics platform.
8GF Score

Get the complete analysis for ATTO

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$21.07
Price